[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0YionrUIUdYL3onPa9vVgm5QeXZO8xtpKyTU6s9uIj4":8,"$fb9MS-RJyZiFonqb9nEiaA5PgrLtSMBDU72DnphhW-xg":55,"$fTDepUKQTKB4A91wQqtAmHSh_KDqq5RbDIJ5kaaeqQgI":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},55030,867330,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//YioT3Y2lC02y9r9C15DHwZvCQCxSAXMI.png","王瑜","新泰市人民医院","肿瘤科","主治医师",240,0,"肺腺癌晚期骶椎转移治疗常用药品安全用药全指南","","https://ystcdn.venuertc.com/venue/AI/87ab55f2-570a-459b-820d-09371b40ec20.jpg","\u003Ch1 id=\"material_title\" class=\"druginfo-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺腺癌晚期骶椎转移治疗常用药品安全用药全指南\u003C/h1>\n\n\u003Cdiv class=\"druginfo-lead\">\n  在提及肿瘤药物，如靶向药、化疗药及辅助骨保护药这类特殊用药时，很多人关心的不只是疗效，更在意怎么用才合适、安全。尤其遇到药物要长期服用、搭配用药多、特殊人群居多的情形，稍有不慎就可能带来风险。这篇指南将围绕肺腺癌晚期骶椎转移常用药品，用通俗直白的方式梳理7大使用要点，为患者及家属提供最实用的用药细节和注意事项。\n\u003C/div>\n\n\u003C!-- 01 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">💊\u003C/span>\n    \u003Cspan>常用药品剂型、成分与分类\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    化疗药、靶向药与骨保护药物是该类治疗常用的三大类型。它们的剂型主要包括口服片剂、胶囊、静脉注射液以及注射用粉剂。各类型药品的常见成分包括：\u003Cbr>\n    \u003Cul>\n      \u003Cli>靶向药：如厄洛替尼（Erlotinib）、吉非替尼（Gefitinib）、阿法替尼（Afatinib）等。多为片剂/胶囊。\u003C/li>\n      \u003Cli>化疗药：例如培美曲塞（Pemetrexed），顺铂等，一般为注射剂。\u003C/li>\n      \u003Cli>骨保护药：典型代表是唑来膦酸（Zoledronic acid）和地诺单抗（Denosumab），多为注射剂。\u003C/li>\n    \u003C/ul>\n    这些药的规格、包装和生产厂牌会有所变化，购药及用药时需详细核对说明书或药师建议，防止误服或套用他药规格。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 02 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">⏰\u003C/span>\n    \u003Cspan>服药时间与方法的关键说明\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    正确掌握服药时间和服用方法，影响药效发挥与副作用发生率。\u003Cbr>\n    \u003Cul>\n      \u003Cli>\u003Cb>靶向药（以吉非替尼、厄洛替尼为例）：\u003C/b>建议空腹（饭前1小时或饭后2小时）整片吞服，不得掰碎、咀嚼或溶解。每日固定时间服用。\u003C/li>\n      \u003Cli>\u003Cb>化疗药（如培美曲塞）：\u003C/b>多为静脉滴注，每周期给药，具体天数由医师制定。滴注前确保水分充足，可减少副作用。\u003C/li>\n      \u003Cli>\u003Cb>骨保护药（如唑来膦酸）：\u003C/b>按疗程静脉注射，注射期间应补充钙剂和维生素D，注射当天需多饮水，降低肾损伤风险。\u003C/li>\n    \u003C/ul>\n    \u003Cblockquote style=\"border-left: 4px solid rgb(64, 158, 255); background: rgb(240, 247, 255); color: rgb(44, 62, 80); margin: 1em 0px; padding: 12px 20px; border-radius: 4px;\">正确做法：靶向药要足量饮水送服，化疗药及骨药遵医嘱按周期用药，不漏服、不自行更换用药时间。\u003C/blockquote>\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 03 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">🛑\u003C/span>\n    \u003Cspan>药品作用机制解析\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>\u003Cb>靶向药：\u003C/b> 选择性阻断肿瘤细胞生存和增殖信号通路（如EGFR通道），减少异常细胞繁殖。\u003C/li>\n      \u003Cli>\u003Cb>化疗药：\u003C/b> 通过抑制DNA、RNA或蛋白质合成，阻断肿瘤细胞分裂，导致其凋亡。\u003C/li>\n      \u003Cli>\u003Cb>骨保护药：\u003C/b> 比如唑来膦酸能抑制骨吸收细胞的活性，地诺单抗阻断核因子κB受体配体，减少骨破坏，预防骨并发症。\u003C/li>\n    \u003C/ul>\n    \u003Cspan>只讲机制，不涵盖用法，此环节关注药效基本原理。\u003C/span>\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 04 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">⚖️\u003C/span>\n    \u003Cspan>用药剂量、调整及漏服应对\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>\u003Cb>靶向药：\u003C/b>绝大多数需每天一次，剂量视具体药物及患者反应调整。漏服时切忌双倍补服，应跳过该次按下一个给药时间服用。\u003C/li>\n      \u003Cli>\u003Cb>化疗药及骨药：\u003C/b>通常按照体表面积和肾功能等综合评估来确定剂量。调整剂量时必须由专业医师根据个体耐受性及实验室检查变化做评估。\u003C/li>\n      \u003Cli>\u003Cb>过量风险：\u003C/b>一旦大量超量服用，需立即联系医疗机构，部分药物如靶向药无法直接用药物拮抗，只能对症处理。\u003C/li>\n    \u003C/ul>\n    正确做法：每次用药须严格核对药名与剂量，发现漏服时按照说明书指引操作，不私自增加剂量。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 05 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">🚫\u003C/span>\n    \u003Cspan>禁忌症与用药限制须知\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>\u003Cb>靶向药：\u003C/b>对药品成分过敏、孕妇、严重肝功能不全者通常禁用。已知有间质性肺病病史的患者须慎用。\u003C/li>\n      \u003Cli>\u003Cb>化疗药：\u003C/b>孕妇、严重免疫抑制、严重肾功能不全者多禁用或需极度慎重。低白细胞、血小板时须推迟用药。\u003C/li>\n      \u003Cli>\u003Cb>骨保护药：\u003C/b>对活性成分过敏、低钙血症未纠正前、严重肾损害患者禁用。\u003C/li>\n    \u003C/ul>\n    \u003Cb>特别提醒：\u003C/b> 靴钙血症未纠正前不得使用唑来膦酸，所有药物孕期用药务必征求医生意见。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 06 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">🔗\u003C/span>\n    \u003Cspan>药物相互作用及合用注意事项\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>靶向药如吉非替尼、厄洛替尼忌合用强CYP3A4抑制剂（某些抗癫痫药、抗生素等），否则可能导致药效过强或不良反应升高。\u003C/li>\n      \u003Cli>顺铂等化疗药不可与氨基糖苷类抗生素同用，否则肾毒风险增高。\u003C/li>\n      \u003Cli>唑来膦酸合用利尿剂、胺碘酮等时需密切监测电解质。\u003C/li>\n    \u003C/ul>\n    正确做法：新增或撤换任何药品前一定要向医生/药师报备，避免自行增减药物和饮食补剂。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 07 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">⚠️\u003C/span>\n    \u003Cspan>常见不良反应、安全处理与何时就医\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>靶向药可能引起皮疹、腹泻、肝酶异常。数据显示，吉非替尼相关皮疹发生率20%-40%。\u003Cbr>\n        出现严重皮肤症状、持续恶心、乏力等，应及时停药并就医。\u003C/li>\n      \u003Cli>化疗药常见骨髓抑制（白细胞、血小板下降）、恶心呕吐、脱发。定期查血、反馈不良反应。\u003C/li>\n      \u003Cli>骨保护药可出现发热、肌肉痛、低钙血症。遇抽搐或手足麻木，要即时处理。\u003C/li>\n    \u003C/ul>\n    正确做法：轻度副作用可在医生指导下对症处理，一旦出现严重持续不适，不延误就医。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 08 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">📦\u003C/span>\n    \u003Cspan>药品储存和有效期管理\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>大部分靶向药、化疗药、骨药应避光、干燥、阴凉或25°C以下储存。部分品种需冷藏或专用保存介质。\u003C/li>\n      \u003Cli>所有注射剂开封后应立即用完，剩余药液不得保存再次应用。\u003C/li>\n      \u003Cli>过期药品应交由药房统一回收，不可随意丢弃或自行服用。\u003C/li>\n    \u003C/ul>\n    正确做法：每次取药前检查外包装、标签完整，发现潮湿、变色等现象时应作废弃处理。【比喻1】药品如生鲜食品，存错、放久都影响品质。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 09 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">🧑‍⚕️\u003C/span>\n    \u003Cspan>特殊人群用药调整与案例提示\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>老年人应根据肝肾功能调整剂量，部分药品老年人耐受性差，剂量可能需下调15%-25%。\u003C/li>\n      \u003Cli>肾功能不全时，唑来膦酸需调整给药频率并限制剂量。\u003C/li>\n      \u003Cli>孕期、哺乳期患者原则禁用所有上述药物，如必须用药必须由专科医师指导。\u003C/li>\n      \u003Cli>青少年、未成年患者需严格权衡风险获益再行用药。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"druginfo-caseblock\">\n      \u003Cspan class=\"druginfo-case\">真实案例：\u003C/span> 一位女性患者接受靶向药期间，因一度漏服，未直接补服，正确地在下次按原时间服用，未出现不良反应。\n    \u003C/div>\n    \u003Cdiv class=\"druginfo-caseblock\">\n      \u003Cspan class=\"druginfo-case\">临床泛用经验：\u003C/span> 化疗药按周期递减剂量，一例老年患者根据耐受性将方案调整后，避免了骨髓抑制问题。\n    \u003C/div>\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 10 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">🔍\u003C/span>\n    \u003Cspan>疗效监测及家庭日常管理要点\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>服药期间需定期抽血、查肝肾功能、血常规和电解质，确保用药安全。\u003C/li>\n      \u003Cli>如合用多种药物，建议家中设置药箱、服药打卡表，防止漏服、多服。\u003C/li>\n      \u003Cli>勿自行停药或随意增减药量，遇难以忍受的副反应可联系就医调整。\u003C/li>\n    \u003C/ul>\n    【比喻2】多药合用，如同列车多节，每节都得在轨、同步运行，才能安全到站。\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 11 -->\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">⭐\u003C/span>\n    \u003Cspan>结语：用药安全小结与温馨提示\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    药物合理使用虽只是治疗过程的一环，但直接关系疗效和身体安全。本文梳理的11大关键点，涵盖了肺腺癌晚期骶椎转移通常应用的靶向药、化疗药、骨保护药在剂型选择、服用方式、储存、特殊人群用药及不良反应等实用细节。\u003Cbr>\n    需要再次强调：规范服药，仔细核对说明书，有任何疑问及时寻求医生或药师帮助。药品专业信息会持续更新，日常用药切莫落入“以旧观新”误区。每一位家属和患者，都是自己健康的守护人。合理用药，每天都安心！😊\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"druginfo-section\">\n  \u003Cdiv class=\"druginfo-section-header\">\n    \u003Cspan class=\"druginfo-icon\">🔖\u003C/span>\n    \u003Cspan>主要参考文献\u003C/span>\n  \u003C/div>\n  \u003Cdiv class=\"druginfo-section-body\">\n    \u003Cul>\n      \u003Cli>Mok, T. S., Wu, Y. L., Thongprasert, S., et al. (2009). Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. \u003Cu>The New England Journal of Medicine\u003C/u>, 361(10), 947-957.\u003C/li>\n      \u003Cli>Paz-Ares, L., Mezger, J., Ciuleanu, T. E., et al. (2012). Pemetrexed in maintenance treatment of locally advanced or metastatic non-small-cell lung cancer: a randomized controlled trial. \u003Cu>Lancet Oncology\u003C/u>, 13(3), 247-255.\u003C/li>\n      \u003Cli>Rosen, L. S., Gordon, D., Tchekmedyian, N. S., et al. (2003). Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial. \u003Cu>Journal of Clinical Oncology\u003C/u>, 21(16), 3150-3157.\u003C/li>\n      \u003Cli>Keating, G. M. (2012). Denosumab: a review of its use in patients with bone metastases from solid tumours. \u003Cu>Drugs\u003C/u>, 72(4), 485-500.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\n\u003Cstyle>\n.druginfo-title {\n  color: #2d415a;\n  font-size: 2.3em;\n  font-weight: 700;\n  letter-spacing: 1.5px;\n  margin-bottom: 18px;\n  padding: 18px 0px 6px 12px;\n  border-left: 8px solid #6495ed;\n  background: linear-gradient(90deg, #eef4fb 60%, #fff 100%);\n  border-radius: 8px;\n}\n\n.druginfo-lead {\n  font-size: 1.15em;\n  color: #31496d;\n  background: #f1f5fa;\n  padding: 18px 16px;\n  border-radius: 10px;\n  margin-bottom: 20px;\n  line-height: 1.7;\n  box-shadow: 0px 2px 5px 0px #eaf2fb;\n}\n\n.druginfo-section {\n  margin: 42px 0 0 0;\n  border-radius: 9px;\n  overflow: hidden;\n  box-shadow: 0 1px 8px 0 #e5eaf3;\n}\n\n.druginfo-section-header {\n  display: flex;\n  align-items: center;\n  font-size: 1.25em;\n  font-weight: bold;\n  background: linear-gradient(90deg, #e8f2fc 70%, #fcfcfc 100%);\n  background-size: cover;\n  padding: 18px 18px 14px 24px;\n  border-bottom: 1.5px solid #d0d8e7;\n  color: #25456a;\n}\n\n.druginfo-icon {\n  font-size: 1.5em;\n  margin-right: 12px;\n}\n\n.druginfo-section-body {\n  background: linear-gradient(90deg, #f6fafd 85%, #fff 100%);\n  padding: 22px 18px 26px 32px;\n  font-size: 1.10em;\n  color: #2f4058;\n  line-height: 2.05;\n}\n\n.druginfo-section-body ul {\n  margin: 10px 0px 18px 20px;\n  padding-left: 18px;\n  list-style: disc;\n}\n\n.druginfo-section-body li {\n  margin-bottom: 7px;\n  line-height: 1.7;\n}\n\n.druginfo-section-body b {\n  color: #127acc;\n}\n\n.druginfo-section-body blockquote {\n  padding: 8px 18px;\n  margin: 14px 0 0 0;\n  background: #cddcf6;\n  border-radius: 6px;\n  color: #394a69;\n  font-size: 1.02em;\n  border-left: 5px solid #73a2ea;\n  font-style: italic;\n}\n\n.druginfo-caseblock {\n  background: #fbeda6;\n  color: #614d12;\n  border-radius: 7px;\n  margin: 20px 0 8px 0;\n  padding: 12px 18px;\n  font-size: 1.05em;\n}\n\n.druginfo-case {\n  color: #e36a1a;\n  font-weight: 600;\n}\n\n@media (max-width: 800px) {\n  .druginfo-title { font-size: 1.3em; }\n  .druginfo-section-header { font-size: 1em; padding: 14px 10px 8px 12px;}\n  .druginfo-section-body { padding: 12px 8px 18px 13px; font-size: 0.98em;}\n  .druginfo-lead { font-size: 0.98em; padding: 10px 7px;}\n}\n\u003C/style>\n","\u003Ch1 id=\"material_title\" class=\"druginfo-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6e",387,"2025-08-01 18:26:42","肺腺癌, 骶椎转移, 安全用药, 化疗药, 靶向药, 骨保护药, 药品禁忌, 用药注意事项","了解肺腺癌晚期骶椎转移常用药品的安全使用，要点涵盖用法、剂量、禁忌等，确保患者用药合理，安全有效。","2025-08-09 23:32:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]